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Abstract 
Background: Diabetes mellitus (DM) is a life-long illness that affects the quality of life, requiring close monitoring 
and control. Type 2 DM is preventable and controllable but increasing cost of care could hinder access to quality 
care because of inability to pay leading to high morbidity, mortality and productivity losses. The people living with 
diabetes mellitus (PLWD) in Nigeria have high risk for high economic burden and catastrophic expenditure not only 
because they make frequent visits to the health facilities, report late with complications but also pay out of pocket at 
the point of accessing care. The aim of this study was to assess the magnitude of economic burden borne and cata-
strophic costs incurred by PLWD in Nigeria.
Methods: Cross-sectional descriptive survey design was used to study a sample of 308 type2 PLWD managed at a 
tertiary health institution, South east Nigeria using semi-structured, prevalidated questionnaire. Data collection period 
was 2 months.
Results: The major findings were economic burden of type 2 DM of N56,245 ($356). Catastrophic direct cost was 
45 % at 30 % threshold (the determinant level for catastrophic spending set). All socio-economic status (SES) groups 
suffered catastrophic expenditure but the poorest quartile had the highest incidence.
Conclusions: Economic burden of DM was high for PLWD who also suffered high catastrophic costs due to the 
impact of out of pocket payment. PLWD need financial protection especially for the poorest since they buy from the 
same market and incur same costs. Policy decision making to assist the PLWD cope with cost of care is needful in 
Nigeria and nations with related problems.
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Background
Diabetes mellitus (DM) is a group of chronic medical 
conditions in which the body’s metabolism is deranged 
either due to absence or insufficient production of insulin 
or the body does not properly respond to insulin; produc-
ing a persistent hyperglycaemic state [1]. The persistent 
hyperglycaemia and associated complications demand 
intensive care and frequent visits to health facilities thus 
increasing the cost of care.
DM affects quality of life, requires close monitoring 
and control. Diabetes mellitus is a growing “epidemic and 
pandemic” [1]. Globally, about 285 million people had 
DM in 2010, projected to double by 2030 [2]. Nigeria’s 
diabetes prevalence of 20.8 million (7 % of population) [3, 
4] and her ranking largest in African regional prevalence 
in 2011 is a great concern [5].
Diabetes is the third cause of death from disease and 
complications [6], second killer non communicable dis-
ease [7], has five fold risks of cardiovascular diseases 
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and three fold of stroke [6]. PLWD in Nigeria have risk 
for high economic burden and catastrophic expenditure 
because the three conditions that predict financial catas-
trophe; healthcare cost paid out of pocket, individuals’ 
inability to pay and absence of prepayment mechanisms 
to pool financial risks [8] are prevalent in Nigeria.
Economic burden in this study means direct cost of 
care. Catastrophic Healthcare expenditure is very high 
healthcare spending in relation to one’s income beyond 
which an individual begins to sacrifice consumption of 
basic needs and use payment coping mechanisms (inte-
rium measures to meet up with payment but in the long 
run increase the total cost). WHO proposed 40  % and 
above of non-subsistence income consumption (non-
food consumption expenditure); that is income avail-
able after basic needs have been met but countries could 
set their thresholds based on their peculiarities [7]. 
Non-food consumption expenditure is used as proxy 
to income because it is sensitive; availability of cash 
and income information are not easily and accurately 
declared in African countries [9, 10].
Previous studies put catastrophic level at 5–40  % [7–
12]. In Nigeria private funding is more than 90  % [9]. 
More than 70 % of the population live below $1 a day [12, 
13] and prepayment mechanism for pooling risk is lack-
ing [9]. Economic impact of healthcare expenditure on 
individuals challenged with illness especially where pre-
payment system is absent is a growing concern [14]. Every 
year more than 150 million individuals in the world face 
financial catastrophe and more than 100 million individ-
uals are pushed into poverty as a direct result of paying 
for health care [7, 8, 14]. This could be worse for patients 
living with Diabetes Mellitus in Nigeria, who receive fre-
quent treatment paid out of pocket coupled with increas-
ing healthcare costs. The burden borne also depends on 
the amount and level of care received [15], purchasing 
power of individuals and social insurance policies of that 
nation [16]. One is bothered that despite the fact that UN 
in 2011 raised the status of non-communicable diseases 
(NCDs) to that of HIV/AIDS, TB and Malaria because 
of their economic and health importance [7, 17], there is 
neither support, nor financial risk protection (exemption) 
for DM which is presently assuming an epidemic pro-
portion [2, 5] and presence of development partners and 
non-governmental organisation (NGOs) have not been 
felt in DM care [17]. The economic importance, compli-
cations and death tolls are compelling national govern-
ments to pay more attention to the impacts of DM [7, 17, 
18] especially with its late diagnosis in Nigeria and some 
other Sub Saharan African countries [19–21].
Evidenced-based data is needed to move DM into 
the health policy agenda of these countries for targeted 
intervention. Unfortunately, there is paucity of data on 
the magnitude of the economic burden borne and cata-
strophic costs incurred by the diabetic Patients in Nige-
ria. The specific objectives of this study assessed;
1. The direct cost borne by PLWD  type 2 in treating 
diabetes.
2. The catastrophic costs incurred by different SES 
groups of PLWD attending a tertiary health institu-
tion in South-East Nigeria with a view of reducing 




A cross sectional descriptive survey design was used for 
this study. This was considered appropriate because the 
‘cost-of-illness estimate’ is a descriptive economic method 
often used to estimate cost of a particular disease [22].
The study was done in a Sate, South East Nigeria, cov-
ering an area of 5834 sq km, 5.8 % of total land mass of 
Nigeria and has a population of 2,833,999 [23]. It is both 
a residential and commercial city and has both urban and 
rural dwellers. The area is made up of civil servants, trad-
ers and farmers. The hospital serves both self and health 
system referred patients. This study was approved by the 
Ethics Research Committee of Federal Medical Centre 
(FMC) Umuahia (FMC/QEH/G.596/VOL.4/006).
Study participants
Population for this study were all type2 DM patients receiv-
ing treatment for diabetes mellitus in the institution. An 
average of 1363 type 2 PLWD received care from the cen-
tre in the last 1  year, (diagnostic index 2009–2011 of the 
Health Records Department) 139 were admitted and man-
aged as in patients while 1224 PLWD were attended to as 
out-patients (target population). Eligibility criteria were age 
between 31 and 65 years, receiving treatment in the centre 
for the past 1  year (July 2011–June 2012) and within the 
2 months data collection period, should be actively involved 
in the management of the condition, well informed about 
the cost of care (have adequate knowledge of cost of care by 
self report) and willing to participate in the study.
Study size
The minimum sample size of 308 was calculated using 
the formula for estimating a single finite proportion 
n = Z2 × p (1 − p)/d2 (Isangedihi et al. 2004) from a tar-
get population of 1224 physician diagnosed type2 diabe-
tes mellitus. Due to lack of information on the proportion 
of type2 DM in economic burden studies, 50 % or 0.5 was 
chosen as p giving an initial sample size of 384.
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2nd stage: In order to obtain the finite population cor-
rection for proportion for a small population the formula 
n = n0/1 + (n0 − 1)/N was used to get 293.13.
3rd stage: Since data were to be collected directly from 
the respondents, it was anticipated that as many as 5 % 
might withdraw from the study prior to its completion 
through possible refusal to continue with the study. Thus 
the formula q = n/1 −  f where q is the adjustment fac-
tor and f is the estimated non response rate was used 
[ANGEL (n.d.).STAT 509] was used. Therefore the final 
sample size was 308. However 292 copies of the question-
naire were found to be correctly and completely filled 
while 16 proposed participants declined.
The Clinics’ appointment registers were used to form a 
sampling frame. The sampling interval for sample recruit-
ment was 3.97. Therefore every 4th person was system-
atically recruited on each clinic day till 308 respondents 
that met the eligibility criteria were selected.
Variables
The variables of interest were: economic burden, cata-
strophic diabetic cost, and socioeconomic status. Eco-
nomic burden was measured by the unit cost of all type 
2 diabetes out patient services received. Catastrophic 
diabetic cost was measured by non food consump-
tion expenditure of the respondents (income) plus the 
direct cost of diabetes. Socioeconomic status groups 
was measured by number of household items owned by 
respondents.
Data collection
A pretested researcher administered semi-structured 
questionnaire was used. It comprised of three sections 
with sixteen questions to elicit responses from respond-
ents based on study objectives. Section A was on demo-
graphic characteristics of respondents; section B, on 
economic burden and section C, on socio economic 
status and catastrophic cost while the coefficient alpha 
(Cronbach’s alpha) method was used to calculate the 
internal consistency reliability of the instrument using 30 
PLWD from a peripheral clinic. The co-efficient of reli-
ability obtained by sections were 0.40, 0.80 and 0.75(sec-
tions A–C), respectively. The low reliability co-efficient 
of 0.4 from section A (demographic characteristics of 
respondents) was related to the heterogeneity created by 
the string (gender). The study focus was not on the influ-
ence of demographic characteristics on economic burden 
nor catastrophic expenditure, therefore it was consid-
ered inconsequential to the study outcome. However, the 
instrument was late updated with outcome of the pre-
tested questionnaire. Informed consents of the patients 
were obtained and assurance of confidentiality of all 
information received given. Participants were informed 
that participation is voluntary. The researchers and the 
three research assistants trained on the purpose of the 
study and how to administer the instrument collected 
the data until the 308 respondents who met the inclusion 
criteria were recruited. The instrument was administered 
within the hours of 8  am and 1  pm while the patients 
awaited their fasting plasma glucose results and to see 
their physicians to avoid disruption of daily clinic activi-
ties and ensure good attention from patients.
Data analysis
The data gathered were collated, cleaned, coded, grouped 
and subjected to descriptive statistics on Statistical Pack-
age for Social Sciences (SPSS) version 16.0 and pre-
sented in percentages, frequencies, means and standard 
deviations.
Data on personal profile were analyzed using frequen-
cies, percentages means and standard deviations. The 
economic burden (direct cost) of DM was articulated 
using bottom-up approach to aggregate the mean cost 
of units of services received through whole encounter 
with the health facilities using 1  month recall period. 
The socio-economic status was determined using prin-
ciple component analysis (PCA) in STATA Software 
based on ownership of household assets. The assets were 
ownership of motorcar, motorcycle, radio, refrigerator, 
television set and bicycle, electric fan and so on. PCA 
was used to generate an assets based socio-economic 
index (grouping all the numerous household items into 
one whole number) which was then used to divide the 
respondents into four socioeconomic quartiles (q1–q4) 
of poorest, poorer, poor and least poor. The first compo-
nent of the PCA was used to derive weights (eigenvec-
tors) for the SES index. The highest weight was assigned 
to refrigerator 0.601, followed by personal computer 
0.57 and so on as in Table 1. Measure of inequality was 
the ratio of the mean non-food expenditure of the poor-
est SES group over that of the least poor. Catastrophic 
DM cost was determined as a proportion of direct DM 
cost and non-food expenditure at fixed threshold of 30 % 
for all SES and 40 and 10  % variable threshold for the 
least poor and the poorest, respectively. The association 
between catastrophic DM costs and socio-economic sta-
tus was assessed using proportions.
Results
Of the 308 questionnaires administered, 292 which 
were properly completed (a return rate of 95  %) were 
analysed and the data presented in Tables. The 16 who 
declined participation reported that they found the asset 
based questions sensitive. From Table 1, the mean age of 
respondents was 54 years, with (67 %) within 50–65 years 
age group. (53  %) of respondents were females. 79  % 
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were married. 41  % had university/college/polytechnic 
education while 28 (10  %) had no formal education. 73 
(25 %) of the respondents were employed by the govern-
ment, 16 (6  %) were in private sector employment, 57 
(20 %) had retired, 92 (32 %) were self-employed, 10 (3 %) 
unemployed, 33 (11 %) were farmers while 11 (4 %) were 
housewives.
Table 2 shows the cost units on which direct cost was 
calculated. Cost of DM diet ranked highest N28,524 
($181) followed distantly by drug and investigations; 
N7701 ($49) and N4236 ($27), respectively. The monthly 
direct cost of DM was N56,245 ($356). In Table  3, the 
respondents were categorized into four socioeconomic 
status groups using (PCA) on STATA software. The first 
component of the PCA was used to assign weights and 
assets based index developed using household assets 
owned by the respondents. The highest weight was 
assigned to refrigerator (.601) followed by personal com-
puter (.57) and so on as in Table  3. The socioeconomic 
status quartiles were named as poorest (q1), poorer (q2) 
poor (q3) and the least poor (q4).
Table 4 showed the mean respondents’ expenditure on 
food and non-food per month. DM costs as a proportion 
of non-food expenditure (N256,000) ($1620) was 20  %. 
Catastrophic expenditure was 45 % at 30 % threshold. In 
Table  5, the mean non-food expenditure was N256,000 
($1620). The poorest (q1) spent N24,617 ($156) and the 
least poor group expended N120,228 ($761) on non-food. 
The ratio of q1/q4 was 1:4.9. The non-food expenditure 
of the least poor was 4.9 times that of the poorest group. 
At 30 % fixed threshold, the catastrophic levels were 78, 
47, 52 and 39  % (q1–q4), respectively while at variable 
threshold of 10 and 40 % threshold (q1 and q4), the costs 
were 86 and 17  %, respectively. Majority that suffered 
catastrophic expenditure at 30 % threshold belong to the 
poorest SES group 58 (78 %) followed by the poor (q3) 38 
(52 %). All SES groups experienced catastrophic expendi-
ture at 10 % threshold but the poorest was worst affected 
64 (86 %) followed by the poorer poor 56 (79 %). Direct 
cost as a proportion of non-food consumption was 20 %.
Table 1 Demographic characteristics of  respondents 
n = 292
Frequency %
Age group (in years)
 30–40 40 14
 41–50 56 19
 50–65 196 67
 Total 292 100
Mean age 54
Gender
 Male 136 46
 Female 156 54
 Total 292 100
Marital status
 Married 231 79
 Single 16 6
 Divorced 1 0.3
 Widow 41 14
 Widower 3 1
 Total 292 100
Highest educational attainment
 No formal education 28 10
 Primary education 76 26
 Junior secondary 5 2
 Senior secondary 63 22
 University/college/polytechnic 119 41
 Post graduate 1 .3
 Total 292 100
Employment status
 Unemployed 10 3
 Govt. employed 73 25
 Private employed 16 6
 Self employed 92 32
 Retired 57 20
 Farming 33 11
 Housewife 11 4
 Total 292 100
Table 2 Direct cost of  DM per  month reflecting unit costs 
n = 292 N(US$)
Cost units Mean (X¯) Standard 
deviation (SD)
Folder 20 (0.13) 25 (0.16)
Drugs 7702 (49) 6922 (44)
Lab. tests/investigations 4932 (31) 5628 (36)
Consultation fees 257 (2) 499 (3)
Insurance premium/co-payment 887 (6) 3351 (21)
Transport 999 (6.3) 3073 (19)
Diabetic diet 28,524 (181) 16,070 (102)
Self-monitoring of glucose 3128 (20) 5984 (38)
Insulin syringe/disposables 959 (6.1) 2575 (16)
Extra house helper 1884 (1.2) 4749 (30)
Physiotherapy 253 (2) 2872 (18)
Dressings 399 (3) 1925 (12)
Cost incurred elsewhere same 
period on DM
3409 (22) 12,797 (81)
Cost of DM related diseases 2894 (18) 5934 (38)
Total 56,245 (356) 28,907 (183)
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Discussions
The economic burden and catastrophic expenditure 
among type2 PLWD in this study was found to be high. 
Worse still, for the lowest SES (q1). All SES groups 
had high catastrophic cost but the poorest are worse 
off. The mean monthly direct cost of N56,245 (US$ 
356) per PLWD is considered so high for respondents’ 
mean non-food consumption expenditure of N256,000 
(US$1620).
DM cost is more than twice non-consumption expend-
iture of q1 N24,617 (US$ 156) and more than 43 % that 
of q4 N120,228 (US$ 761). DM cost in this study appears 
higher than in previous studies with (US $ 197) per 
annum in outpatient study in Karachi Pakistan in 2007 
Table 3 Categorization of respondents into socioeconomic status on assets based index n = 292
Household item Weight Yes No
Radio .53 284 (97 %) 8 (3 %)
Television .24 277 (95 %) 15 (5 %)
Air conditioner .48 29 (10 %) 262 (90 %)
Bicycle .003 19 (6 %) 273 (94 %)
Motorcycle −.012 25 (9 %) 267 (91 %)
Car .34 106 (36 %) 186 (64 %)
Refrigerator .601 169 (58 %) 123 (42 %)
Power generating set .29 182 (62 %) 110 (38 %)
Gas cooker .07 75 (26 %) 217 (74 %)
Electric fan −.033 254 (87 %) 38 (13 %)
Microwave oven .18 39 (13 %) 252 (87 %)
Washing machine .30 14 (5 %) 276 (95 %)
Personal computer .57 32 (11 %) 257 (89 %)
Socioeconomic status Quartiles Frequency Percentage
Least poor Q4 72 24.7
Poor Q3 73 25
Poorer poor Q2 73 25
Poorest Q1 74 25.3
Total 292 100
Table 4 Respondents’ monthly expenditure and mean catastrophic DM cost at 30 % threshold N(US$)
Respondents’ expenditure Mean (X¯) Standard deviation (SD)
Food purchased 31,800 (201) 39,629 (251)
Food produced 9924 (63) 15,233 (96)
Clothing 28,300 (179) 33,884 (215)
Rent 24,400 (154) 53,672 (340)
Health care 15,400 (98) 22,679 (144)
Cooking fuel 5272 (33) 6766 (43)
Educational expenses 84,800 (537) 133,723 (846)
Durable goods 64,001 (405) 22,855 (145)
Community welfare 11,800 (75) 22,332 (141)
Transportation 12,000 (76) 14,879 (94)
Utilities 10,026 (64) 12,214 (77)
Non-food expenditure 256,000 (1620) 731,710 (4631)
Total expenditure 553,725 (3505) 999,078 (6323)
DM costs as a proportion of non-food expenditure 20.4 % 11 %
Catastrophic DM cost 45 % 88 %
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[24] and $ 2144.2 per PLWD per year in a West Afri-
can region study in 2009; [25] but lower than N180,582 
(US$1143) in cost of DM foot ulcer [19] in Nigeria 2007.
Diet ranking is highest followed by drugs and investiga-
tions differed from previous studies where drugs ranked 
highest. This high cost may not be unrelated to increasing 
healthcare cost, high cost of diabetic supplies, frequent 
visit to hospitals, wide claims on DM diet for “cure”, on 
media and streets by traditional healers, late reporting 
with complications and co-morbidities that are known to 
increase cost burden of DM [18, 22, 26]. High cost of care 
is likely to impede effective DM care due to low purchas-
ing power, out of pocket payment at the point of need and 
absence of prepayment mechanisms [12]. Lack of access 
to effective DM could expose patients complications that 
will reduce the quality of life, increase morbidity, mortal-
ity and productivity loses which has far reaching implica-
tions for development. The only way to explain how they 
paid this huge direct cost is use of payment coping mech-
anisms; interim measures to meet up with health cost 
(social support, borrowing, sale of assets, cutting back 
on consumption of basic needs, skipping appointments 
or abandoning treatment when feeling well, instalment 
payment, etc. [12, 27, 28]. Unfortunately financing health 
care with payment mechanisms further inflates the total 
costs and push the patients deeper into ‘hidden’ poverty 
[28]. Catastrophic direct cost was 45  % at 30  % thresh-
old implying that 45 % of the 292 respondents, spent 30 % 
and above of their non food consumption expenditure 
(income) on diabetic care.
The catastrophic DM expenditure at 30  % threshold 
within the SES quartiles (q1–q4) of 58 (78 %), 34 (47 %), 
38 (52 %) and 28 (39 %), respectively is considered quite 
high especially for the poorest with meagre income but 
must buy at same rate with rich at the facility or forfeit 
treatment. Previous studies had described this cata-
strophic cost as financial expenditure that is crippling to 
household and disrupts their standards of living [29, 30].
Using fixed threshold could mask degree of financial 
catastrophe and the inequity in financial access to care 
between poorest and least poor [11, 15]. For example at 
30  % threshold in the present study, catastrophic cost 
was high among all the socioeconomic status groups. The 
remaining 70 % of non-food expenditure would amount 
to N17,232 ($109) for the poorest and almost five times 
higher for the least poor, N84,160 ($533). Thus the least 
poor cannot be said to be facing as great catastrophe as 
the poorer ones. The least poor could cut back on his 
luxuries to cope but the poorest is left with only N17,232 
($109) to survive on. The use of variable threshold to 
measure catastrophe gave a higher overall and disaggre-
gated levels of catastrophe which is considered a better 
measure reflecting the differences in purchasing power 
between the rich and the poor [11].
For example at a variable threshold of 10  % for the 
poorest and 40  % for the least poor, the catastrophic 
costs were 64 (87 %) and 12 (17 %), respectively. At the 
expenditure of 10  % non food more than 80  % experi-
enced financial distress while the least poor will spend 
almost five times of the same and only 17 % will expe-
rience catastrophe. The richest quartile would need to 
spend about 40  % of their non-food consumption on 
DM before having the risk of being tipped into poverty 
while the poorest quartile would need to spend 1/10 
that of the richest to be thrown into poverty. Measure 
of inequality is the ratio of q1/q4 non-food expenditure 
1:4.9. Catastrophic cost in this study were higher than 
previous studies. Although there was no Nigerian Cat-
astrophic DM cost study found in literature other cost 
of illness studies (TB, Malaria, etc.) in Nigeria demon-
strated high catastrophic cost. Onoka and colleagues 
examined catastrophic health expenditure in Nigeria 
at variable and fixed thresholds; observed 14.8 % catas-
trophe at 40  % non-food expenditure with 22.6 and 
7.6 % of the poorest and richest, respectively. At a vari-
able threshold of 5 and 29.6  % for the poorest and the 
Table 5 Respondents’ expenditure per month by socioeconomic status, catastrophic expenditure and the monthly mean 
cost of treating DM at the centre in N(US$)
Expenditure Q1 the poorest n = 74 Q2 the poorer poor n = 73 Q3 the poor n = 73 Q4 the least poor n = 72
Non-food expenditure 24,616 (156) 43,166 (273) 67,991 (430) 120,228 (761)
Ratio of non-food (qn/q1) 1 1.75 2.76 4.88
Ratio qn/q4 0.20 0.36 0.57 1
Catastrophic threshold
 Threshold of 40 catastrophic 42(57 %) 20(27 %) 13(18 %) 12(17 %)
 Threshold of 30 catastrophic 58(78 %) 34(47 %) 38(52 %) 28(39 %)
 Threshold of 10 catastrophic 64(87 %) 56(78 %) 50(69 %) 25(35 %)
 Mean cost of treatment of DM at the  
centre
56,245 (356) 56,245 (356) 56,245 (356) 56,245 (356)
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richest the catastrophic level were 44.7 and 12.0 % [12]. 
However Ichoku and colleagues observed, 3–5  % cata-
strophic spending at 10 % threshold [10]. In a household 
survey of catastrophic health expenditure in South east 
Nigeria (n = 167) highest proportion was noted among 
the poorest [31]. At a variable threshold of 5 and 29.6 %, 
(q1 and q4) catastrophic level were 44.7 and 12  %, 
respectively [31].
As revealed in studies (11, 12, 13) it was not somewhat 
a surprise to find catastrophic expenditure in a country 
that has the highest DM burden in Africa with no pre-
payment mechanism to pool financial risk, >70 % of the 
population live below $1 per day, >90 % use private fund-
ing for health services and late reporting for care. How-
ever, it becomes a great concern considering that PLWD 
will need to contend with these costs throughout lifetime.
Secondly the magnitude of economic burden and cata-
strophic cost observed in this study in South east Nige-
ria is major concern because, the area is one of the oil 
producing states with better resource allocation and the 
National Health Insurance Scheme which presently cov-
ers some categories of government workers, is being 
implemented.
The disproportionate, experience of catastrophe tilt-
ing towards lower socioeconomic groups in the present 
study means that the poor is not protected from impact 
of out of pocket spending (OOPS) and increasing care 
cost (inequity) [32].
Urgent re-visitation of the current health financing 
strategy to provide for financial risk protection of the 
poor through policy decision making is needful to reduce 
economic burden of DM. Government should adopt 
financial strategies that rely less on private funding.
Study limitations
The study has some limitations. Due to the 1 month 
recall some cost items may be missed due to forgetful-
ness. Another limitation is that cost estimation may risk 
double counting because of cost of co-morbidity (cost-
of-illness problem). Multiple accesses for care within the 
period of study may lead to loss of unit costs. Further-
more self-report of costs can give an underestimation 
or exaggeration of the problem. Asset based informa-
tion was observed to be sensitive to some respondents. 
The study was confined to only one hospital in the state 
therefore findings cannot be generalized. There was no 
Nigerian patient-based cost of DM and catastrophic 
expenditure out-patient study cited as non was seen in 
literature review.
Conclusions
This study demonstrated a high economic burden 
of type2 diabetes mellitus that led to catastrophic 
expenditure especially among the lowest socioeconomic 
status group. Consistent with previous studies, the results 
illustrate the difference in level of catastrophic spending. 
This calls for re-visitation of the present health financing 
policy to accommodate pro-poor policies that will make 
DM care free at the delivery point, subsidize costs or pro-
vide a wider coverage of National Health Insurance.
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